Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction
Basic & Clinical Pharmacology & Toxicology · 2025-05 · 136 (5)
DOI: 10.1111/bcpt.70026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 31.03.2025. Verfasst von Ana M Briones und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Inflammation, Endothelium, Vascular, Inflammation Mediators, Cardiovascular Diseases. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Agencia Estatal de Investigación, Comunidad de Madrid, Fundación Española de Arteriosclerosis.
Abstract (Originalsprache)
Excessive local inflammation is a common mechanism in many cardiovascular diseases (CVDs) such as hypertension, atherosclerosis and aortic aneurysms. In endothelial cells, inflammatory cytokines such as interferons, tumour necrosis factor alpha or interleukins increase oxidative stress and contractile prostanoids and the expression of adhesion molecules that reduce nitric oxide (NO) availability and bind leucocytes, thereby impairing endothelial function. Despite this evidence, anti‐inflammatory therapies are not yet indicated for the treatment of most CVD. Resolution of inflammation is mediated by a family of specialized pro‐resolving mediators (SPMs) that act on cognate G protein–coupled receptors to limit immune cell infiltration and initiate tissue repair. SPMs, generated from omega‐3 and omega‐6 polyunsaturated fatty acids, belong to four major families: lipoxins, resolvins, protectins and maresins. SPM receptors are expressed in immune and vascular cells where they regulate important processes such as phagocytosis and polarization, production of cytokines, NO and prostacyclin, and modulation of smooth muscle cell phenotype. Growing evidence in animal models demonstrates that activation of SPM receptors can protect vascular function and structure and provide beneficial effects in various CVD. We will review recent advances in the role of inflammation and SPMs in vascular (dys)function in hypertension, atherosclerosis, and aortic aneurysms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
- Hospital La Paz Institute for Health Research (IdiPaz), Madrid, Spain.
- CIBER Cardiovascular (CIBERCV), Madrid, Spain.
- Department of Basic Health Sciences, Universidad Rey Juan Carlos, Madrid, Spain.
- Department of Physiology, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
- Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.
ORCID-Profile: Ana M Briones, María J Alonso
Förderung
- Agencia Estatal de Investigación
- Comunidad de Madrid
- Fundación Española de Arteriosclerosis
- Instituto de Salud Carlos III
- European Union
- European Commission
Zitieren
APA
Briones, A. M., Hernanz, R., García-Redondo, A. B., Rodríguez, C., Blanco-Colio, L. M., Val-Blasco, A., Alonso, M. J., & Salaices, M. (2025). Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction. Basic & Clinical Pharmacology & Toxicology, 136(5). https://doi.org/10.1111/bcpt.70026
Vancouver
Briones AM, Hernanz R, García-Redondo AB, Rodríguez C, Blanco-Colio LM, Val-Blasco A, et al. Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction. Basic & Clinical Pharmacology & Toxicology. 2025;136(5). doi:10.1111/bcpt.70026
BibTeX
@article{Briones2025,
author = {Briones, Ana M and Hernanz, Raquel and García-Redondo, Ana B and Rodríguez, Cristina and Blanco-Colio, Luis M and Val-Blasco, Almudena and Alonso, María J and Salaices, Mercedes},
title = {Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
volume = {136},
number = {5},
doi = {10.1111/bcpt.70026}
}
EUVIMED